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REFLECTIONS OF THE PIONEERSThe first Maze procedureJames L. Cox, MDBy the time the first Maze procedure was performed in
1987, we were already operating on approximately 120
patients a year for other types of cardiac arrhythmias. We
began to focus on atrial fibrillation in a systematic fashion
in our laboratory at Duke University in 1980 by first devel-
oping an animal model that was more clinically relevant
than existing models.1 The main preconditions for the
model were that no scars could be placed on either atrium
and that the pericardium could not be entered because scars
or pericarditis might obscure the characteristics of any atrial
fibrillation caused by the model itself. The canine model in-
cluded a sterile left thoracotomy and the introduction of
a left atrial pressure catheter and a biopsy needle through
a purse-string suture in the extrapericardial left superior
pulmonary vein. Mitral insufficiency was created by trans-
ecting the chordae tendineae in a stepwise fashion until the
left atrial pressure increased to approximately 20 mm Hg.
The animals were allowed to recuperate for at least 3
months when atrial fibrillation could be easily induced.
This new model allowed us to assess the effects of various
surgical interventions without mapping them. The ability
to map atrial fibrillation awaited the development of a com-
puterized multipoint digital mapping system developed in
the mid-1980s by Dr John P. Boineau, Dr Richard Schuess-
ler, and Barry Branham in our laboratory at Washington
University in St Louis.
One day in June 1986, I received a phone call from an air-
line captain from Cyprus named George Dheere. Captain
Dheere was 37 years old and had experienced a severe tran-
sient ischemic attack as the result of new-onset atrial fibril-
lation. He was immediately anticoagulated and grounded,
a personally devastating sequence of events. Captain
Dheere had read an article that we had written in 1982 en-
titled ‘‘Surgical Management of Atrial Fibrillation,’’2 in
which we described how atrial fibrillation could be confined
to the left atrium using the left atrial isolation procedure.
Despite our discouraging Captain Dheere, he flew to
St Louis a few days later and insisted that we perform
some type of surgical procedure for his atrial fibrillation.
During Dheere’s 1-week stay, he visited our research labo-
ratories and discovered that we had also recently developed
an operation called the ‘‘atrial transection procedure,’’
which was the first procedure designed specifically toFrom the Division of Cardiothoracic Surgery, Washington University School of
Medicine, Barnes-Jewish Hospital, St Louis, Mo.
Address for reprints: James L. Cox, MD, 13523 Rosewood Lane, Naples, FL 34119
(E-mail: jamescoxmd@aol.com).
J Thorac Cardiovasc Surg 2011;141:1093-7
0022-5223/$36.00
Copyright  2011 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2010.12.012
The Journal of Thoracic and Carabolish atrial fibrillation and had a cure rate of 100% in
our atrial fibrillation animal model. He insisted on undergo-
ing an atrial transection procedure, but we refused on
grounds that it was not ready for clinical application. Dis-
gruntled and disappointed, he returned to Cyprus in atrial fi-
brillation despite amiodarone therapy. In September 1986,
however, Captain Dheere returned to St Louis and informed
us that he was not going to leave until we did something sur-
gically to alleviate his atrial fibrillation. After extensive dis-
cussions among the clinical and experimental cardiology and
surgical teams, and after securing institutional review board
approval from Barnes Hospital, we decided to proceed with
an atrial transection procedure. Captain Dheere remained
arrhythmia-free postoperatively for 5 months, but then viral
pericarditis and recurrent atrial fibrillation developed.
Fortunately, during the intervening months we had finally
begun to accumulate sufficient critical data from our animal
models, and from our mapping of patients with atrial fibril-
lation who were undergoing surgery for Wolff–Parkinson–
White syndrome, we had begun to construct an accurate
picture of the electrophysiologic basis of atrial fibrillation.
Through the laborious work of Drs John Boineau and
Richard Schuessler using their array of more than 250 bipo-
lar electrodes experimentally and 156 electrodes clinically,
and by using the computer programs developed by Barry
Branham, the electrical events that were occurring in the
atrium during atrial fibrillation were finally elucidated. Al-
though the data were still incomplete, it was apparent that
all atrial fibrillation, once established, was characterized
by the presence of multiple large constantly shifting
macro-reentrant circuits in the atria. Unfortunately, these
maps also documented that the macro-reentrant circuits of-
ten remained in one location for only 200 ms, making map-
guided surgery impractical. That left us with only one viable
option. If we were going to treat atrial fibrillation surgically,
it was now apparent that we had to develop a procedure that
made it impossible for the atrium to fibrillate at all. The only
way to do that would be to place incisions in the atria close
enough together that macro-reentrant circuits could not
form between them. Fortunately, the macro-reentrant cir-
cuits that we had mapped in both dogs and patients were
physically relatively large, that is, more than 5 to 6 cm in
diameter in the left atrium and much larger than that in
the right atrium. Therefore, atrial incisions placed no
more than 5 to 6 cm apart should theoretically prevent the
development of macro-reentrant circuits anywhere in the
atria. It was clear that if macro-reentrant circuits could
not develop in the atria, then the atria could not fibrillate.
The dilemma was how to place enough lesions on the
atria to preclude the development of atrial macro-reentrydiovascular Surgery c Volume 141, Number 5 1093
FIGURE 1. These diagrams demonstrate the concept of the Maze procedure first envisioned in early 1987. A, Two-dimensional representation of the anat-
omy of the atria with the right atrium harboring the orifices of the superior and inferior venae cavae, as well as the right atrial appendage. The left atrium has
the pulmonary veins and left atrial appendage. The atrial septum divides the 2 with the SA node in the top of the right atrium near the septum and the AV node
at the bottom of the septum connecting to the ventricles. B, Arrows depict the propagation of a normal sinus rhythm beat from its source (starburst) in the SA
node to all of the atrial myocardium and then to its termination at the AV node. C, Heavy lines represent lines of conduction block created by lesions in the
atria. By placing the lesions in the pattern of a maze, they can be placed close enough to prevent the development of macro-reentry anywhere in either atrium
and still allow the sinus impulse to activate all of the atrial myocardium except the encircled pulmonary veins and excised atrial appendages (D). AV,
Atrioventricular; IVC, inferior vena cava; LAA, left atrial appendage; SA, sinoatrial; SVC, superior vena cava; RAA, right atrial appendage.
Reflections of the Pioneers Cox(fibrillation) and leave behind an atrium that could be
activated by the sinus node and still contract effectively.
That question was answered one Saturday afternoon
while I was studying some of the Boineau–Schuessler ex-
perimental maps of atrial fibrillation in my office at Barnes
Hospital. To better visualize the relationship between atrial
anatomy and atrial electrophysiology, a rectangle was
drawn to represent the entire mass of both atria 2-dimen-
sionally. The rectangle was then arbitrarily partitioned
into the left atrium (with its pulmonary vein orifices) and
the right atrium (with the superior and inferior venae cavae
orifices). Both atria had appendages. The atrial septum was
placed between the right and left atria. The sinus (sinoatrial
[SA]) node was placed at the top of the septum, and the
atrioventricular (AV) node was placed at the bottom of the
septum. This, then, represented all of the pertinent anatomy1094 The Journal of Thoracic and Cardiovascular Surof both atria (Figure 1, A) on which known electrophysiol-
ogy could be superimposed.
The pattern of activation during normal sinus rhythm that
we had mapped numerous times in humans was then super-
imposed on this schematic rectangular diagram of the atria
(Figure 1, B). We had also recorded several bouts of atrial
flutter and atrial fibrillation, and those maps were also
superimposed on the schematic rectangular atria. While
studying this 2-dimensional representation of the atria
with the superimposed electrophysiology of atrial fibrilla-
tion, I suddenly realized that everything necessary to abol-
ish atrial fibrillation, while leaving the atrial activation and
contraction intact afterward, could be accomplished by cre-
ating a pattern of lesions in the atria that was essentially that
of a simple maze (Figure 1, C). The lesions could be placed
close enough to prevent atrial macro-reentry, and if placedgery c May 2011
FIGURE 2. Three-dimensional representation of the original Maze I pro-
cedure. A ‘‘window’’ has been drawn in the posterior left atrium to allow
visualization of the location of themitral valve, atrial septum, and AV node.
Cox Reflections of the Pioneersin a maze pattern, the SA node could serve as the site of
entry of electrical activity into the atria and the AV node
as its site of exit from the atria. One contiguous ‘‘true route’’
of conduction would be left intact between the entrance and
exit sites, and multiple ‘‘blind alleys’’ off this main conduc-
tion route would allow activation of all of the atrial myocar-
dium, thereby preserving atrial contractility (Figure 1, D).
One entrance, one exit, one true route between the two
and multiple blind alleys . the pattern and principle of
a maze.
Once I realized that atrial lesions placed in a maze pattern
was the answer to the surgical treatment of atrial fibrillation,
the next problem was to determine exactly where those le-
sions should be placed on the actual 3-dimensional atria.
Remembering that John Boineau had several hundred ca-
nine hearts stored in formaldehyde in our research labora-
tory, I immediately went to our laboratory and dissected
several complete atrial blocks (right atrium, atrial septum,
and left atrium) completely away from the remaining por-
tions of heart and great vessels. After drying them, a black
dot was placed at the site of the anatomic SA node with
a marking pen. Three intersecting lines were then placed
around 3 sides of the SA node region to indicate the site
of potential incisions. By leaving one side open, the sinus
impulse could propagate only in that direction. By follow-
ing this logic, lines were subsequently drawn close enough
together to prevent the large macro-reentrant circuits from
occurring (thereby precluding the ability of the atria toThe Journal of Thoracic and Carfibrillate) while at the same time ‘‘directing’’ the propaga-
tion of the imaginary sinus impulse in any desired direction.
Once it was certain that the right atrium, the left atrium, and
the septum would be activated in this manner, attention was
directed toward preventing the impulse from ‘‘doubling
back’’ on itself, thereby creating a single large macro-
reentrant circuit. Finally, the ability of the sinus impulse
to reach the AV node was ensured so that it could activate
the ventricles as well (Figure 2).
Three such atrial ‘‘blocks’’ with their black lines were
saved until the following Monday when the pattern was rec-
reated on a fresh canine heart using atrial incisions rather
than black lines. After suturing the incisions closed, the
fresh atrial block was fixed in formaldehyde and used there-
after as a guide for the performance of this newly named
‘‘Maze procedure’’ in live animals (Figure 3). The Maze
procedure was subsequently shown to abolish atrial fibrilla-
tion in our animal model, and long-term experimental stud-
ies proved that it was safe and permanent.3 Most important,
we went to great lengths to document that atrial transport
function remained intact postoperatively.
In the late summer of 1987, a cardiologist from Alton,
Illinois, near St Louis, called about his cousin, who had
severe atrial flutter/fibrillation. He had failed all medical
therapy, including amiodarone. After a long, detailed
workup and several intense discussions, the Barnes Hospital
Institutional Review Board approved a ‘‘one-time’’ trial of
the Maze procedure in this one patient, and on September
25, 1987, I performed the first clinical Maze procedure
(Figure 4). The patient remained in sinus rhythm until the
seventh postoperative day, when atrial fibrillation devel-
oped. Digoxin and procainamide were administered, and
he quickly converted to sinus rhythm. One month after hos-
pital discharge, the patient presented with a severe case of
procainamide-induced lupus syndrome, diagnosed by
Dr Bruce Lindsay, now the Chief of Electrophysiology at
the Cleveland Clinic. The procainamide was discontinued.
During the next month, he remained in sinus rhythm and
his lupus syndrome relented. His digoxin was discontinued
by Dr Lindsay the next month, and he remained in sinus
rhythm. On his return outpatient visit at that time, the emi-
nent electrophysiologist Dr Maurits Allessie from Maas-
tricht, The Netherlands, was visiting our institution, and I
felt privileged and fortunate to have him document that
the patient was in normal sinus rhythmwith nomedications.
The patient had no further episodes of atrial flutter or fibril-
lation, was not anticoagulated, and took no antiarrhythmic
drugs. He eventually had a recurrence of atrial fibrillation
just 1 month shy of the 20-year anniversary of his Maze pro-
cedure, but his arrhythmia is controlled on antiarrhythmic
medication.
Having maintained weekly telephone contact with my
office and with the first Maze patient himself during late
1987, Captain Dheere knew exactly what was unfoldingdiovascular Surgery c Volume 141, Number 5 1095
FIGURE 3. Photograph taken by Research Fellow Byung-Chul Chang, now the Professor and Chief of Cardiothoracic Surgery at Yonsei University in
Seoul, Korea, in early 1987 of the author performing the first experimental Maze procedure in the Cardiothoracic Surgery Research Laboratories at
Washington University in St Louis.
Reflections of the Pioneers Coxin St Louis. Thus, after a few months, Captain Dheere in-
sisted on having his previous atrial transection procedure
‘‘converted’’ to theMaze procedure. After waiting 5 months
after the first Maze procedure, we performed the ‘‘conver-
sion’’ from an atrial transection procedure to a Maze proce-
dure on Captain Dheere in February 1988. This conversion
resulted in a pattern of atrial lesions that was essentially the
same as the iteration that wewould later call the ‘‘Maze III’’
procedure. Unfortunately, on the eighth postoperative day,
intractable atrial flutter developed in the patient. He re-
mained in this rhythm until September 7, 1988, when heFIGURE 4. Two frames from a movie of the first Maze procedure performed cl
median sternotomy (the patient’s head is to the left) showing the multitude of wi
electrodes. One bay of the electrodes is being connected to one of the compute
incisions of the first Maze procedure.
1096 The Journal of Thoracic and Cardiovascular Surwas finally documented to have the first example ever re-
corded of what would later be termed ‘‘atypical left atrial
flutter.’’ This iatrogenic arrhythmia was using the coronary
sinus as a critical ‘‘bridge,’’ allowing conduction to occur
across the left atrial isthmus between the inferior pulmonary
veins and the posterior mitral valve annulus. We interpreted
this to mean that the cryolesion that had been placed on the
coronary sinus at the time of his second surgery had failed.
The circuit was interrupted by Dr Michael Cain, then Chief
of Electrophysiology at Washington University and Barnes
Hospital, using catheter fulguration. Captain Dheereinically on September 25, 1987. A, Overhead view of the heart exposed via
res extending from 3 silastic electrode arrays containing a total of 156 atrial
r cable connectors at the top of the table. B, One of the initial right atrial
gery c May 2011
FIGURE 5. Captain George Dheere running up the steps of the CuriumRomanAmphitheatre in his native Cyprus. This photograph was taken by the author
20 months after Captain Dheere’s Maze procedure was performed. Captain Dheere was the first person to ever undergo a surgical procedure specifically
designed to ablate atrial fibrillation, the second to undergo a Maze procedure, the first to undergo a re-do Maze procedure, the first to undergo the equivalent
of the Maze III procedure, and the first to experience the iatrogenic problem of atypical left atrial flutter.
Cox Reflections of the Pioneersremained free of atrial arrhythmias for the remainder of his
life with no medications (Figure 5). In addition, he ulti-
mately was reinstated as a commercial airline pilot with
his beloved Cypress Airways. One of my saddest days oc-
curred in the summer of 2003, when I was called by one
of Captain Dheere’s daughters in Cyprus and told that he
had died suddenly of a heart attack just shy of his 54th birth-
day. I have often said that without the courage and persis-
tence of this brave airline pilot from Cyprus, the
development of the Maze procedure would have been
delayed at least 10 years and perhaps would never have oc-
curred at all. My personal experience with Captain GeorgeThe Journal of Thoracic and CarDheere and the Maze procedure only strengthens my
long-held belief that there are no courageous surgeons,
only courageous patients.References
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